TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Super Synbiotics AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
14,160
|
13,702
|
16,179 |
Financial expenses |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
36
|
-1,115
|
1,744 |
EBITDA |
10
|
-1,114
|
1,744 |
Total assets |
6,668
|
6,099
|
9,623 |
Current assets |
6,614
|
6,049
|
9,573 |
Current liabilities |
2,286
|
2,042
|
2,342 |
Equity capital |
4,381
|
4,057
|
7,282 |
- share capital |
51
|
47
|
49 |
Employees (average) |
1
|
3
|
2 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
65.7%
|
66.5%
|
75.7% |
Turnover per employee |
14,160
|
4,567
|
8,090 |
Profit as a percentage of turnover |
0.3%
|
-8.1%
|
10.8% |
Return on assets (ROA) |
0.5%
|
-18.3%
|
18.1% |
Current ratio |
289.3%
|
296.2%
|
408.8% |
Return on equity (ROE) |
0.8%
|
-27.5%
|
23.9% |
Change turnover |
-515
|
-1,990
|
-1,327 |
Change turnover % |
-4%
|
-13%
|
-8% |
Chg. No. of employees |
-2
|
1
|
0 |
Chg. No. of employees % |
-67%
|
50%
|
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.